[2] Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing | @KathrynP_phd @MDouglas_MS @JuliaTrosman | https://t.co/k43PMyM4WS
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
Saving this for reading later.
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
RT @JulieKaylor: "71% of the payer[s] cover pediatric Exome Sequencing, ... they see merit in available interventions or in ending the diag…
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
"71% of the payer[s] cover pediatric Exome Sequencing, ... they see merit in available interventions or in ending the diagnostic odyssey." @InformedDNA helped craft the first WES payer coverage policy with mednec criteria in 2015 paving the way for pt car
RT @TheACMG: Check out this month’s @GIMJournal #FeatureArticle at https://t.co/wfaM2owyD5 #genetics #genomics #medicalgenetics #clinicalge…
RT @TheACMG: Check out this month’s @GIMJournal #FeatureArticle at https://t.co/wfaM2owyD5 #genetics #genomics #medicalgenetics #clinicalge…
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
RT @GIMJournal: February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequenci…
February #FeatureArticle: Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS) https://t.co/9LaBxmfKon https://t.co/QN4
RT @Aleks_Rajkovic: UCSF researcher Kathryn Phillips studies the economics of next generation sequencing reimbursement. Insurance companies…
Exome sequencing: value is in the eye of the beholder - https://t.co/enVTyIDQWg a commentary from @DrGrosseCDC on our US private payers on insurance coverage for pediatric and prenatal exome sequencing paper - https://t.co/UotIFEOlbQ
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
UCSF researcher Kathryn Phillips studies the economics of next generation sequencing reimbursement. Insurance companies are covering pediatric but not prenatal exome sequencing. This is not optimal for our patients. https://t.co/x0VQRc6Hrc
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
RT @GIMJournal: What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
What insurers say about paying for exome sequencing https://t.co/BRzYmeRW6f #genomics https://t.co/ehKbRsIT9C
71% of payers in the US cover pediatric ES despite perceived insufficient evidence as they recognize the significant implications of the test. However, no payer covers prenatal ES due to lack of in utero interventions. @GIMJournal https://t.co/fHk3pEDQWX
@UCSF_TRANSPERS (w/ UCSF P3EGS) found 71% of private payers in the study cover pediatric Exome Sequencing (ES). Payers’ views on clinical utility are expanding to include informational utility. However, no payers covered prenatal ES due to lack of utility.
@UCSF_TRANSPERS (w/ UCSF P3EGS) found 71% of private payers now cover pediatric Exome Sequencing (ES). Payers’ views on clinical utility are expanding to include informational utility. However, no payers covered prenatal ES due to lack of evidence. [https:
RT @MuinJKhoury: Most payers in the US cover pediatric exome sequencing despite perceived insufficient evidence, because they saw merit in…
Most payers in the US cover pediatric exome sequencing despite perceived insufficient evidence, because they saw merit in available interventions or in ending diagnostic odyssey. None cover prenatal exome sequencing. Via @GIMJournal https://t.co/6OkpuSTIAW